Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

pierre fabre australia pty ltd - vinorelbine tartrate, quantity: 13.85 mg/ml (equivalent: vinorelbine, qty 10 mg/ml) - injection, concentrated - excipient ingredients: water for injections - vinorelbine pierre fabre is indicated for the treatment of advanced breast cancer after failure of standard therapy, as a single agent or in combination; and as first line treatment for advanced non-small cell lung cancer, as a single agent or in combination. vinorelbine pierre fabre is indicated for the treatment, in combination with cisplatin, of patients with completely resected non-small cell lung cancer of stage ib or greater.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - vinorelbine tartrate -

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - vinorelbine tartrate -

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

pierre fabre medicament australia pty ltd - vinorelbine tartrate 27.7mg equivalent to vinorelbine 20 mg - soft gelatin capsule - 20 mg - active: vinorelbine tartrate 27.7mg equivalent to vinorelbine 20 mg excipient: edible ink red ethanol gelatin glycerol   anidrisorb 85/70 85% phosal 53 mct iron oxide yellow macrogol 400 medium-chain triglycerides purified water   titanium dioxide

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

pierre fabre medicament australia pty ltd - vinorelbine tartrate 41.55mg equivalent to vinorelbine 30 mg - soft gelatin capsule - 30 mg - active: vinorelbine tartrate 41.55mg equivalent to vinorelbine 30 mg excipient: edible ink red ethanol gelatin glycerol   anidrisorb 85/70 85% phosal 53 mct iron oxide red macrogol 400 medium-chain triglycerides purified water   titanium dioxide

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

pierre fabre medicament australia pty ltd - vinorelbine tartrate 55.4mg equivalent to vinorelbine 40 mg - soft gelatin capsule - 40 mg - active: vinorelbine tartrate 55.4mg equivalent to vinorelbine 40 mg excipient: edible ink red ethanol gelatin glycerol   anidrisorb 85/70 85% phosal 53 mct iron oxide red iron oxide yellow macrogol 400 medium-chain triglycerides purified water   titanium dioxide

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

pierre fabre medicament australia pty ltd - vinorelbine tartrate 110.8mg equivalent to vinorelbine 80 mg - soft gelatin capsule - 80 mg - active: vinorelbine tartrate 110.8mg equivalent to vinorelbine 80 mg excipient: edible ink red ethanol gelatin glycerol   anidrisorb 85/70 85% phosal 53 mct iron oxide yellow macrogol 400 medium-chain triglycerides purified water   titanium dioxide

Belgicko - angličtina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

accord healthcare b.v. - vinorelbine tartrate 13,85 mg/ml - eq. vinorelbine 10 mg/ml - concentrate for solution for infusion - 10 mg/ml - vinorelbine tartrate 13.85 mg/ml - vinorelbine

Belgicko - angličtina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

accord healthcare b.v. - vinorelbine tartrate 13,85 mg/ml - eq. vinorelbine 10 mg/ml - concentrate for solution for infusion - 10 mg/ml - vinorelbine tartrate 13.85 mg/ml - vinorelbine

Belgicko - angličtina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - vinorelbine tartrate 13,85 mg/ml - eq. vinorelbine 10 mg/ml - concentrate for solution for infusion - 10 mg/ml - vinorelbine tartrate 13.85 mg/ml - vinorelbine